Life Insurance Corporation Of India has informed the Exchange about the notification of Govt of India for the approval of voluntary retirement of Shri Dinesh Pant.
Ask the chart: “Has this stock recovered from similar drawdowns before?”
AI equity note (bull/bear, numbers, sources) — coming soon
Management guidance consistency — coming soon
Latest filings
NSE announcements · newest firstLife Insurance Corporation Of India has informed the Exchange about the voluntary retirement of Shri Dinesh Pant approved by the Govt. of India.
Life Insurance Corporation Of India has informed the Exchange about the Investors'Meet attended by the representatives of the Corporation on September 22, 2026.
Life Insurance Corporation Of India has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Life Insurance Corporation Of India has informed the Exchange about the Investors' Meet attended by the representatives of the Corporation on September 21, 2026.
Key MetricsFull financials →
P/E (TTM)
8.6×
EPS ₹47.49
P / Book
2.71×
BVPS ₹151
ROE
37.6%
FY26, avg equity
Net margin
10.7%
FY26
Revenue YoY
+6.7%
Q1 FY27
Net profit YoY
+24.0%
Q1 FY27
Debt / equity
0.00×
₹0 Cr debt
Div. yield
2.44%
₹10.00 in 12 months
From NSE filings (consolidated) and the last close.
Shareholding Pattern Jun 2026
Promoter pledge: none reported
Peer Comparison
| Company | P/E | P/B | ROE | Margin |
|---|---|---|---|---|
| LICI₹5.17L Cr | 8.6× | 2.71× | 37.6% | 10.7% |
| SBILIFE₹1.75L Cr | 67.2× | 8.82× | 13.8% | 2.4% |
| HDFCLIFE₹1.15L Cr | 58.4× | 6.05× | 21.4% | 2.4% |
| ICICIPRULI₹67,102 Cr | 41.7× | 4.88× | 12.5% | 3.0% |
| MFSL₹50,053 Cr | 364.3× | 9.48× | 2.0% | 0.2% |
| CANHLIFE₹14,317 Cr | 109.0× | 8.76× | 7.9% | 1.3% |
Life Insurance: the companies closest in market value, of the 6 in that basic industry whose filings we hold. Computed from each company's NSE filings (up to Q1 FY27) and the last close; hover a column for its definition.
Forensic Flags3 Watch
Operating cash flow was -0.33× net profit
Cumulative over FY25–FY26 (2 years).
Free cash flow was negative in 2 of the last 2 years
Operating cash flow less capital expenditure, as filed.
Effective tax rate averaged 0%
Tax over pre-tax profit, last 2 years. The base corporate rate is about 25%.
6 checks within their thresholds
Debt to equity is 0.00×
As at 2026-06-30.
Exceptional items above 5% of pre-tax profit in 0 of the last 2 years
FY25–FY26.
Promoter holding is 96.50%, +0.00 points over a year
2026-06-30 against 2025-06-30.
No promoter shares are pledged
Shareholding pattern as at 2026-06-30.
No auditor change or resignation filings in three years
From NSE announcements on record.
Results were filed late in 0 of the last 6 quarters
Slowest filing came 58 days after the period end.
Computed from NSE filings (consolidated). Colours follow fixed thresholds, shown on hover. These are facts about the filings, not advice. 3 checks not run for lack of data.
Formula Scores
Piotroski F-score: not computed · FY to 2026-03-31the tests use working capital and gross margin, which a bank's or insurer's statements do not have
Altman Z-score: not computed · FY to 2026-03-31not defined for a bank's or insurer's balance sheet
Graham number: 758.06 ₹ per share · FY to 2026-03-31√(22.5 × earnings per share × book value per share): the price at which P/E × P/B = 22.5 (a P/E of 15 at a P/B of 1.5)
- earnings per share: 90.84
- book value per share: 281.16 — owners' equity over shares (paid-up capital / face value)
Inputs: earnings per share 90.84 (2026-03-31) · owners' equity ₹1,77,833 Cr (2026-03-31) · paid-up capital ₹6,325 Cr (2026-03-31) · face value 10 (2026-03-31)
a number the book uses as a ceiling for a defensive investor's purchase price; it is arithmetic on two reported figures, not a valuation
Source: Benjamin Graham, The Intelligent Investor (1949; the 22.5 in the 1973 edition's criteria for the defensive investor)
Sloan accrual ratio: not computed · FY to 2026-03-31operating cash flow is not comparable for a bank or insurer
Each score is its published formula applied to the company's own filings (consolidated); open one for the tests, the inputs and the paper. Arithmetic on the filings, not a view on the stock.